IP Library Granted Patent US 7,491,545
Granted Patent B2
US 7,491,545 · App. 10/673,409 · Granted Feb 17, 2009

Excitation ratiometric fluoroscent biosensor for zinc ion at picomolar levels

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,491,545
App. No.
10/673,409
Granted
Feb 17, 2009
Kind
B2
Abstract

A highly selective and sensitive of a carbonic anhydrase-based method for measurement of zinc ion by an excitation ratiometric format based on resonance energy transfer: i.e., where the zinc ion level is transduced as the ratio of fluorescence intensities excited at two different excitation wavelengths, is provided. The method can be used very well in a fluorescence microscopy format. A detection limit of about 10 pM in zinc buffered systems, a ten to one thousand-fold improvement on the Fura indicators (which respond to Ca and Mg as well), and a one hundred thousand-fold improvement on the recently described FuraZin-1 is achieved.

Claims (24)

1. A method for quantitation of zinc ion in a sample comprising:

i) disposing in said sample a donor fluorescent sulfonamide fluorophore and a carbonic anhydrase protein having conjugated thereto an acceptor fluorophore, wherein the binding of said donor fluorophore to the conjugated carbonic anhydrase is dependent upon the presence of zinc ion complexed to the conjugated carbonic anhydrase;

ii) measuring the intensity of a fluorescence emission of the acceptor fluorophore upon excitation of the donor fluorophore at a first excitation wavelength;

iii) measuring the intensity of a fluorescence emission of the acceptor fluorophore upon excitation of the acceptor fluorophore at a second excitation wavelength;

iv) obtaining the ratio of the intensities measured in steps ii) and iii) and;

v) relating the quantity of zinc ion in the sample to the ratio obtained in step iv).

2. The method of claim 1 , in which the donor fluorophore is Dapoxyl sulfonamide.

3. The method of claim 1 , in which the acceptor fluorophore is pyrano[3,2-g:5,6-g′]diquinolin-13-ium,6-[2-carboxyl-4 (or 2-carboxyl-5) [carboxamido-N-pentyl-N′-maleimide]phenyl]-1,2,10,11-tetrahydro-1,2,2,10,10,11-hexamethyl-4,8-bis(sulfomethyl); inner salt.

4. The method of claim 1 , in which the carbonic anhydrase is human carbonic anhydrase II having a cysteine residue substituted for serine residue 166 or having a cysteine residue substituted for histidine 36 and the acceptor fluorophore is conjugated to said cysteine residue.

5. The method of claim 3 , in which the carbonic anhydrase is human carbonic anhydrase II having a cysteine residue substituted for serine residue 166 or having a cysteine residue substituted for histidine 36 and the acceptor fluorophore is conjugated to said cysteine residue.

6. The method of claim 1 , in which the donor fluorophore is selected from the group consisting of dansylamide and ABDN.

7. The method of claim 6 , in which the acceptor fluorophore is tetramethyl rhodamine maleimide.

8. The method of claim 1 , in which the acceptor fluorophore is tetramethyl rhodamine maleimide.

9. A method for quantitation of zinc ion in a sample comprising:

i) disposing in said sample a donor fluorescent sulfonamide fluorophore and a fusion protein comprising a carbonic anhydrase protein and a fluorescent protein acceptor fluorophore, wherein the binding of said donor fluorophore to the fusion protein is dependent upon the presence of zinc ion complexed to the carbonic anhydrase domain of the fusion protein;

ii) measuring the intensity of a fluorescent emission of the acceptor fluorophore upon excitation of the donor fluorophore at a first excitation wavelength;

iii) measuring the intensity of a fluorescent emission of the acceptor fluorophore upon excitation of the acceptor fluorophore at a second excitation wavelength;

iv) obtaining the ratio of the intensities measured in steps ii) and iii) and;

v) relating the quantity of zinc ion in the sample to the ratio obtained in step iv).

10. The method of claim 9 , in which the fluorescent protein is Green Fluorescent Protein, Enhanced Green Fluorescent Protein, Yellow Fluorescent Protein, DsRed, or Blue Fluorescent Protein.

11. The method of claim 10 , in which the donor fluorophore is selected from the group consisting of dansylamide and ABDN.

12. The method of claim 10 , in which the donor fluorophore is Dapoxyl sulfonamide.

13. The method of claim 9 , in which the sample comprises a living cell.

14. The method of claim 9 , in which the donor fluorophore is selected from the group consisting of dansylamide and ABDN.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 15, 2016
From: UNIVERSITY OF MARYLAND BALTIMORE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 038916/0353 →
Continuity (3)
Provisional Application 6041651500 · Oct 8, 2002
Provisional Application 6041465700 · Oct 1, 2002
Related Publication 20040185518A1 · Sep 23, 2004